Viewing Study NCT04789434


Ignite Creation Date: 2025-12-25 @ 2:36 AM
Ignite Modification Date: 2025-12-27 @ 11:49 PM
Study NCT ID: NCT04789434
Status: UNKNOWN
Last Update Posted: 2021-11-22
First Post: 2021-03-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: PD-1 Inhibitor Tislelizumab Maintenance Therapy in Newly Diagnosed DLBCL Patients After ASCT
Sponsor: Ruijin Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module